Inactive Instrument

Press Releases Merrion Pharmaceuticals Plc

Equities

3MP

IE00B282VY28

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Merrion Pharmaceuticals : Notice of General meetings	16-08-26	PU
Merrion Pharmaceuticals : Proposed liquidation	16-08-23	PU
Merrion Pharmaceuticals : Disposal Completion	15-12-17	PU
Merrion Pharmaceuticals : Interim results for the six month period ended 30 June 2015, Dublin, Ireland 30 September 2015	15-10-01	PU
Merrion Pharmaceuticals : Announces Continuing Progress of Oral Insulin Projects Using Merrion Pharmaceuticals' GIPET Technology under license to its partner Novo Nordisk A/S	15-09-02	PU
Merrion Pharmaceuticals : Annual Report and Notice of AGM	15-08-18	PU
Merrion Pharmaceuticals : Annual Report	15-07-01	PU
Merrion Pharmaceuticals : Announces Completion of Disposal of Citywest Facility	15-01-15	PU
Merrion Pharmaceuticals : "Merrion" or the "Company") announces the proposed disposal of its Citywest facility for a consideration of €2,175,000	14-12-18	PU
Merrion Pharmaceuticals : Receives Milestone Payment Following Successful Completion of a Phase I Study of Novo Nordisk A/S Oral GLP-1 Analogue (NN9928) Using Merrion Pharmaceuticals' GIPET Technology	14-09-04	PU
Merrion Pharmaceuticals : Hovione and Merrion Pharmaceuticals Announce Strategic Partnership on Use of Merrion's GIPET Technology	14-07-15	PU
Merrion Pharmaceuticals : Directorate Change	14-06-18	PU
Merrion Pharmaceuticals : Annual Report and Notice of AGM and EGM	14-06-18	PU
Merrion Pharmaceuticals' : GIPET Technology Progresses with Novo Nordisk Oral Insulin Development	14-05-30	PU
Merrion Pharmaceuticals : FDA meeting clears way for MER-101 in treatment of early breast cancer	14-04-11	PU
Merrion Pharmaceuticals Plc : Novo Nordisk A/S Successfully Completes Phase I Trial of its Proprietary Oral Insulin (NN1956) using Merrion Pharmaceuticals' GIPET® Technology.	14-03-07	PU
Merrion Pharmaceuticals Plc : Appointment of Director	13-12-23	PU
Merrion Pharmaceuticals Plc : Appointment of CEO and Chairman	13-12-23	PU
Merrion Pharmaceuticals Plc : Interim Results for the Six Months Ended 30 June 2013	13-09-30	PU
Merrion Pharmaceuticals Plc : Result of AGM	13-09-18	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Merrion Pharmaceuticals Plc

Equities

3MP

IE00B282VY28

Press Releases

Filters